EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Targeted Therapy–Induced Interstitial Lung Disease in NSCLC: Mechanisms, Clinical Signatures, and a Precision Medicine Roadmap

Jia-Feng Wang iD, Lei-Lei Jiang, Meng-Chuan Wang, Yang-Ling Li

Drug Design, Development and Therapy · 2026-04 · Volume 20 · 1-22

DOI: 10.2147/dddt.s600434 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-04. Verfasst von Jia-Feng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Fir…. Hauptthemen laut MEDLINE: Precision Medicine, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Interstitial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineLung NeoplasmsCarcinoma, Non-Small-Cell LungLung Diseases, InterstitialMolecular Targeted TherapyAntineoplastic AgentsHumansProtein Kinase InhibitorsImmunoconjugates

Stichwörter der Autor:innen

antibody–drug conjugatesinterstitial lung diseasenon-small cell lung cancerprecision oncologytargeted therapy

Substanzen

Antineoplastic AgentsProtein Kinase InhibitorsImmunoconjugates

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzho…
  • The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, People's Republic of China.
  • Affiliated Cixi Hospital, Wenzhou Medical University, Ningbo, Zhejiang, People's Republic of China.

ORCID-Profile: Jia-Feng Wang

Zitieren

APA

Wang, J. F., Jiang, L. L., Wang, M. C., & Li, Y. L. (2026). Targeted Therapy–Induced Interstitial Lung Disease in NSCLC: Mechanisms, Clinical Signatures, and a Precision Medicine Roadmap. Drug Design, Development and Therapy, Volume 20, 1-22. https://doi.org/10.2147/dddt.s600434

Vancouver

Wang JF, Jiang LL, Wang MC, Li YL. Targeted Therapy–Induced Interstitial Lung Disease in NSCLC: Mechanisms, Clinical Signatures, and a Precision Medicine Roadmap. Drug Design, Development and Therapy. 2026;Volume 20:1-22. doi:10.2147/dddt.s600434

BibTeX
@article{Wang2026,
  author = {Wang, Jia-Feng and Jiang, Lei-Lei and Wang, Meng-Chuan and Li, Yang-Ling},
  title = {Targeted Therapy–Induced Interstitial Lung Disease in NSCLC: Mechanisms, Clinical Signatures, and a Precision Medicine Roadmap},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--22},
  doi = {10.2147/dddt.s600434}
}
Kostenlos starten →